147 related articles for article (PubMed ID: 36353307)
1. Effectiveness of Mammography Screening on Breast Cancer Mortality - A Study Protocol for Emulation of Target Trials Using German Health Claims Data.
Braitmaier M; Kollhorst B; Heinig M; Langner I; Czwikla J; Heinze F; Buschmann L; Minnerup H; García-Albéniz X; Hense HW; Karch A; Zeeb H; Haug U; Didelez V
Clin Epidemiol; 2022; 14():1293-1303. PubMed ID: 36353307
[TBL] [Abstract][Full Text] [Related]
2. German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data.
Heinze F; Czwikla J; Heinig M; Langner I; Haug U
BMC Cancer; 2023 Sep; 23(1):852. PubMed ID: 37697304
[TBL] [Abstract][Full Text] [Related]
3. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
4. Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme.
Buschmann L; Wellmann I; Bonberg N; Wellmann J; Hense HW; Karch A; Minnerup H
BMC Med; 2024 Jan; 22(1):43. PubMed ID: 38287392
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
6. German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.
Heinig M; Schäfer W; Langner I; Zeeb H; Haug U
BMC Public Health; 2023 Aug; 23(1):1678. PubMed ID: 37653487
[TBL] [Abstract][Full Text] [Related]
7. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
8. [Cancer screening in Germany: availability and participation].
Starker A; Buttmann-Schweiger N; Krause L; Barnes B; Kraywinkel K; Holmberg C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1491-1499. PubMed ID: 30406892
[TBL] [Abstract][Full Text] [Related]
9. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
11. Assessing and Explaining Geographic Variations in Mammography Screening Participation and Breast Cancer Incidence.
Czwikla J; Urbschat I; Kieschke J; Schüssler F; Langner I; Hoffmann F
Front Oncol; 2019; 9():909. PubMed ID: 31620366
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. [Mammography screening in Germany].
Diekmann S; Diekmann F
Radiologe; 2008 Jan; 48(1):17-25. PubMed ID: 18030441
[TBL] [Abstract][Full Text] [Related]
15. Does a decision aid improve informed choice in mammography screening? Study protocol for a randomized controlled trial.
Reder M; Kolip P
BMC Womens Health; 2015 Jul; 15():53. PubMed ID: 26198675
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
von Fournier D
Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
[TBL] [Abstract][Full Text] [Related]
17. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial.
Hegenscheid K; Hoffmann W; Fochler S; Domin M; Weiss S; Hartmann B; Bick U; Hosten N
Am J Prev Med; 2011 Oct; 41(4):421-7. PubMed ID: 21961470
[TBL] [Abstract][Full Text] [Related]
18. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
